Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Non Operating Income (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Non Operating Income data on record, last reported at $893000.0 in Q3 2025.

  • For Q3 2025, Non Operating Income fell 79.17% year-over-year to $893000.0; the TTM value through Sep 2025 reached $644000.0, down 69.98%, while the annual FY2024 figure was $4.3 million, 8.68% up from the prior year.
  • Non Operating Income reached $893000.0 in Q3 2025 per GOSS's latest filing, down from $5.1 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $6.5 million in Q2 2023 and bottomed at -$7.7 million in Q4 2023.
  • Average Non Operating Income over 4 years is $676533.3, with a median of $587000.0 recorded in 2022.
  • The widest YoY moves for Non Operating Income: up 1013.8% in 2023, down 447.69% in 2023.
  • A 4-year view of Non Operating Income shows it stood at -$1.4 million in 2022, then crashed by 447.69% to -$7.7 million in 2023, then rose by 27.76% to -$5.6 million in 2024, then skyrocketed by 116.04% to $893000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $893000.0 in Q3 2025, $5.1 million in Q2 2025, and $172000.0 in Q1 2025.